Clinical Trial Update: Quadruple Immunotherapy for Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating quadruple immunotherapy for recurrent Neuroblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Hong Kong Children's Hospital | Conditions: Neuroblastoma Recurrent | Phase 2 | Status: RECRUITING